<DOC>
	<DOCNO>NCT00784433</DOCNO>
	<brief_summary>Moderate alcohol may beneficial diabetic</brief_summary>
	<brief_title>The CArdiovasCulAr Diabetes &amp; Ethanol ( CASCADE ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Established diagnosis type 2 diabetes Male female alcohol abstainer ( 1 drink/week ) Age 4075 yr Clinically stable , history stroke myocardial infarction major surgery within previous 3 month The use RI shortacting analog insulin/ pump therapy . Patients 12 injection per day NPH longacting analog eligible inclusion Triglycerides &gt; 500 mg/dL HbA1c &lt; 7 &gt; 10 % Serum creatinine &gt; 2 mg/dl Liver dysfunction ( great 2fold elevation ALT 3fold elevation AST ) Evidence severe diabetes complication ( proliferative retinopathy overt nephropathy ) Autonomic neuropathy manifest postural hypotension hypoglycemia unawareness Patients chronic hepatitis ( C , B ) Use drug might significantly interact alcohol sedative , antihistamine , anticoagulant Presence active cancer , chemotherapy within past 3 year Major illness may require hospitalization A high potential addictive behavior base physician 's assessment personal family history addiction , alcoholism , alcohol abuse Pregnant lactate woman Participation another trial active intervention</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>alcohol diabetes CVD</keyword>
</DOC>